Supernus Pharmaceuticals Inc (SUPN)
30.83
+0.56
(+1.85%)
USD |
NASDAQ |
May 03, 16:00
30.84
+0.01
(+0.03%)
After-Hours: 20:00
Supernus Pharmaceuticals Shares Outstanding: 54.74M for Feb. 20, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
February 20, 2024 | 54.74M |
December 31, 2023 | 54.72M |
November 01, 2023 | 54.63M |
September 30, 2023 | 54.63M |
August 01, 2023 | 54.59M |
June 30, 2023 | 54.59M |
May 03, 2023 | 54.48M |
April 17, 2023 | 54.48M |
March 31, 2023 | 54.47M |
February 22, 2023 | 54.38M |
December 31, 2022 | 54.25M |
October 31, 2022 | 54.06M |
September 30, 2022 | 54.05M |
August 01, 2022 | 53.50M |
June 30, 2022 | 53.49M |
May 02, 2022 | 53.41M |
April 18, 2022 | 53.41M |
March 31, 2022 | 53.39M |
March 30, 2022 | 53.39M |
December 31, 2021 | 53.26M |
November 01, 2021 | 53.18M |
September 30, 2021 | 53.18M |
August 02, 2021 | 53.15M |
June 30, 2021 | 53.14M |
April 30, 2021 | 53.02M |
Date | Value |
---|---|
April 16, 2021 | 53.02M |
March 31, 2021 | 52.99M |
February 28, 2021 | 52.92M |
December 31, 2020 | 52.87M |
October 30, 2020 | 52.69M |
September 30, 2020 | 52.67M |
July 31, 2020 | 52.66M |
June 30, 2020 | 52.62M |
April 29, 2020 | 52.54M |
April 16, 2020 | 52.54M |
March 31, 2020 | 52.54M |
February 13, 2020 | 52.53M |
December 31, 2019 | 52.53M |
October 31, 2019 | 52.46M |
September 30, 2019 | 52.46M |
August 05, 2019 | 52.45M |
June 30, 2019 | 52.45M |
May 01, 2019 | 52.38M |
April 12, 2019 | 52.37M |
March 31, 2019 | 52.37M |
February 13, 2019 | 52.32M |
December 31, 2018 | 52.32M |
November 01, 2018 | 52.26M |
September 30, 2018 | 52.26M |
August 03, 2018 | 52.21M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
52.45M
Minimum
Jun 30 2019
54.74M
Maximum
Feb 20 2024
53.39M
Average
53.18M
Median
Shares Outstanding Benchmarks
Dynavax Technologies Corp | 130.61M |
Ligand Pharmaceuticals Inc | 17.71M |
Pacira BioSciences Inc | 46.50M |
Esperion Therapeutics Inc | 185.05M |
Collegium Pharmaceutical Inc | 31.96M |